The XpresSpa Group said it has signed a contract with the Port Authority of New York and New Jersey (PANYNJ) to provide diagnostic COVID-19 testing at Newark Liberty International Airport (EWR) through its XpresCheck brand.
The deal follows the successful launch in late June of the XpresCheck pilot program at John F. Kennedy International Airport (JFK) in the Arrivals Hall at Terminal 4.